Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2013.07.13
第二届董事会第二十五次会议决议公告
2013.07.13
第二届监事会第二十三次会议决议公告
2013.07.13
北京市中伦律师事务所关于公司终止股票期权激励计划的法律意见书
2013.07.13
关于对外投资的公告
2013.07.13
关于终止实施公司股票期权激励计划的公告
2013.05.29
2012年年度权益分派实施公告
2013.05.23
2012年年度股东大会决议公告
2013.05.23
2012年年度股东大会的法律意见书
2013.04.26
关于首次公开发行前已发行股份上市流通的提示性公告
2013.04.12
2012年度监事会报告
第一页
上一页
126
127
128
129
130
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
